# EDGAR Filing Document

**Accession Number:** 0001680367
**File Stem:** 0001680367-23-000021
**Filing Date:** 2023-2
**Character Count:** 16305
**Document Hash:** ba3cf613c757037315b198c5e44fb6c2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001680367-23-000021.hdr.sgml**: 20230223

**ACCESSION NUMBER**: 0001680367-23-000021

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20230223

**DATE AS OF CHANGE**: 20230223

**EFFECTIVENESS DATE**: 20230223

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Shattuck Labs, Inc.
- **CENTRAL INDEX KEY:** 0001680367
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 812575858
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-269955
- **FILM NUMBER:** 23660322

**BUSINESS ADDRESS:**
- **STREET 1:** 500 W. 5TH STREET
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701
- **BUSINESS PHONE:** 512-900-4690

**MAIL ADDRESS:**
- **STREET 1:** 500 W. 5TH STREET
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701

**As filed with the Securities and Exchange Commission on February 23, 2023**

**Registration No. 333-**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

***UNDER***

***THE SECURITIES ACT OF 1933***

**Shattuck Labs, Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Delaware** | **81-2575858** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification Number)** |

---

**500 W. 5th Street, Suite 1200** 

**Austin, TX 78701** 

**(512) 900-4690**

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)**

**Shattuck Labs, Inc. 2020 Equity Incentive Plan**

**Shattuck Labs, Inc. 2020 Employee Stock Purchase Plan**

**(Full title of the plan)**

**Taylor Schreiber, M.D., Ph.D.**

**Chief Executive Officer**

**Shattuck Labs, Inc. 500 W. 5th Street, Suite 1200**

**Austin, TX 78701**

**(512) 900-4690** 

**(Name, address, including zip code, and telephone number, including area code, of agent for service)**

***With copies to:***

---

| | |
|:---|:---|
| **Ryan A. Murr<br>Branden C. Berns<br>Gibson, Dunn & Crutcher LLP<br>555 Mission Street<br>San Francisco, CA 94105-0921<br>(415) 393-8373** | **Erin Ator Thomson<br>General Counsel, Corporate Secretary, and Chief Ethics and Compliance Officer<br>Shattuck Labs, Inc.<br>500 W. 5th Street, Suite 1200<br>Austin, TX 78701<br>(512) 900-4690** |

---

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**EXPLANATORY NOTE**

This Registration Statement on Form S-8 is being filed by Shattuck Labs, Inc. (the "Registrant"), relating to 1,695,623 shares of its common stock, par value $0.0001 per share (the "Common Stock"), available for issuance pursuant to awards under the Shattuck Labs, Inc. 2020 Equity Incentive Plan (the "2020 Plan") and 423,905 shares of Common Stock issuable under the Shattuck Labs, Inc. 2020 Employee Stock Purchase Plan (the "ESPP" and, together with the 2020 Plan, the "Plans").

Pursuant to General Instruction E of Form S-8, the contents of the Registration Statements on Form S-8 previously filed with the Securities and Exchange Commission ("Commission") on October 19, 2020 (<u>[Re](https://www.sec.gov/Archives/edgar/data/1680367/000119312520272169/d91773ds8.htm)[g](https://www.sec.gov/Archives/edgar/data/1680367/000119312520272169/d91773ds8.htm)[istration No. 333-249555](https://www.sec.gov/Archives/edgar/data/1680367/000119312520272169/d91773ds8.htm)</u>), on March 16, 2021 (<u>[Re](https://www.sec.gov/Archives/edgar/data/1680367/000119312521082783/d74744ds8.htm)[g](https://www.sec.gov/Archives/edgar/data/1680367/000119312521082783/d74744ds8.htm)[istration No. 333-254340](https://www.sec.gov/Archives/edgar/data/1680367/000119312521082783/d74744ds8.htm)</u>) and on March 15, 2022 (<u>[Registration No. 333-263552](https://www.sec.gov/Archives/edgar/data/1680367/000119312522075328/d225360ds8.htm)</u>), which relate to the Plans, are incorporated herein by reference and made a part hereof, except for those items being updated by this Registration Statement.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

---

| | |
|:---|:---|
| **Item 8.** | **Exhibits** |
| **Exhibit Number** | **Description of Exhibit** |
| 4.1 | <u>[Amended and Restated Certificate of Incorporation of Shattuck Labs, Inc. (incorporated by reference from Exhibit 3.1 to the Company's Current Report on Form 8-K filed on October 14, 2020 (Commission File No. 001-39593)).](https://www.sec.gov/Archives/edgar/data/1680367/000119312520269417/d72237dex31.htm)</u> |
| 4.2 | <u>[Amended and Restated Bylaws of Shattuck Labs, Inc. (incorporated by reference from Exhibit 3.2 to the Company's Current Report on Form 8-K filed on October 14, 2020 (Commission File No. 001-39593)).](https://www.sec.gov/Archives/edgar/data/1680367/000119312520269417/d72237dex32.htm)</u> |
| 5.1\* | <u>[Opinion of Gibson, Dunn & Crutcher LLP.](gdclegalopiniontoforms-8.htm)</u> |
| 23.1\* | <u>[Consent of Independent Registered Public Accounting Firm.](s-8kpmgconsent.htm)</u> |
| 23.2\* | <u>[Consent of Gibson, Dunn & Crutcher LLP (included in Exhibit 5.1).](gdclegalopiniontoforms-8.htm)</u> |
| 24.1\* | <u>[Power of Attorney (included on signature page hereto).](#i3beae36865dd4764a3bc74cab97926ca_45)</u> |
| 99.1 | <u>[2020 Equity Incentive Plan (incorporated by reference from Exhibit 10.9 of the Company's Amendment No. 2 to Registration Statement on Form S-1 filed on October 8, 2020 (Commission File No. 333-248918)).](https://www.sec.gov/Archives/edgar/data/1680367/000119312520263321/d69956dex109.htm)</u> |
| 99.2 | <u>[2020 Employee Stock Purchase Plan (incorporated by reference from Exhibit 10.10 of the Company's Amendment No. 2 to Registration Statement on Form S-1 filed on October 8, 2020 (Commission File No. 333-248918)).](https://www.sec.gov/Archives/edgar/data/1680367/000119312520263321/d69956dex1010.htm)</u> |
| 107.1\* | <u>[Filing Fee Table](filingfeefor2023s-8.htm)</u> |

---

\* Filed herewith.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, as amended (the "Securities Act"), the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Austin, Texas, on February 23, 2023.

---

| | |
|:---|:---|
| **Shattuck Labs, Inc.** | **Shattuck Labs, Inc.** |
| By: | /s/ Dr. Taylor Schreiber |
| Name: | Dr. Taylor Schreiber |
| Title: | Chief Executive Officer |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Dr. Taylor Schreiber and Andrew R. Neill, and each of them, his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this Registration Statement, and any registration statement relating to the offering covered by this Registration Statement and filed pursuant to Rule 462 under the Securities Act, and to file the same, with exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact and agents or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, the following persons have signed this Registration Statement in the capacities and on the date(s) indicated.

---

| | | |
|:---|:---|:---|
| **<u>Signature</u>** | **<u>Title</u>** | **<u>Date</u>** |
| /s/ Dr. Taylor Schreiber | Chief Executive Officer and Director | February 23, 2023 |
| Dr. Taylor Schreiber | (*principal executive officer*) |  |
| /s/ Andrew R. Neill | Chief Financial Officer | February 23, 2023 |
| Andrew R. Neill | (*principal financial and accounting officer*) |  |
| /s/ Dr. George Golumbeski | Chairman of the Board | February 23, 2023 |
| Dr. George Golumbeski |  |  |
| /s/ Helen M. Boudreau | Director | February 23, 2023 |
| Helen M. Boudreau |  |  |
| /s/ Dr. Neil Gibson | Director | February 23, 2023 |
| Dr. Neil Gibson |  |  |
| /s/ Dr. Carrie Brownstein | Director | February 23, 2023 |
| Dr. Carrie Brownstein |  |  |
| /s/ Michael Lee | Director | February 23, 2023 |
| Michael Lee |  |  |
| /s/ Tyler Brous | Director | February 23, 2023 |
| Tyler Brous |  |  |

---

## Ex-Filing

**Exhibit 107.1**

**Calculation of Filing Fee Tables**

**FORM S-8**

(Form Type)

**Shattuck Labs, Inc.**

(Exact Name of Registrant as Specified in its Charter)

<u>Table 1: Newl</u>y <u>Re</u>g<u>istered Securities</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security <br>Type** | **Security Class Title (1)** | **Fee <br>Calculation <br>Rule** | **Amount Registered** | **Proposed <br>Maximum <br>Offering Price <br>Per Share** | **Maximum <br>Aggregate <br>Offering <br>Price** | **Fee Rate** | **Amount of Registration Fee** |
| Equity | Common Stock, par value $0.0001 per share ("Common Stock") to be issued pursuant to the Shattuck Labs, Inc. 2020 Equity Incentive Plan (the "2020 Plan") | Rule 457(a) (2) | 1695623 | $4.31 | $7308136 | $110.2 per $1,000,000 | $806 |
| Equity | Common Stock to be issued pursuant to the Shattuck Labs, Inc. 2020 Employee Stock Purchase<br>Plan (the "ESPP") | Rule 457(a) (3) | 423905 | $3.66 | $1551493 | $110.2 per $1,000,000 | $171 |
| Total Offering Amounts | Total Offering Amounts | Total Offering Amounts | Total Offering Amounts |  | $8859629 |  | $977 |
| Total Fee Offsets | Total Fee Offsets | Total Fee Offsets | Total Fee Offsets |  |  |  | $— |
| Net Fee Due | Net Fee Due | Net Fee Due | Net Fee Due |  |  |  | $977 |

---

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement on Form S-8 shall also cover any additional shares of Common Stock that may become issuable under the 2020 Plan or the ESPP as a result of any stock dividend, stock split, recapitalization or other similar transaction, and any other securities with respect to which the outstanding shares are converted or exchanged.

(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act, based upon the average of the high and low prices of the Registrant's Common Stock on the Nasdaq Global Select Market on February 17, 2023.

(3) Estimated solely for the purposes of calculating the registration fee pursuant to Rule 457 under the Securities Act, based upon a 15% discount from the average of the high and low prices of the Registrant's Common Stock on the Nasdaq Select Global Market on February 17, 2023, such discount representing the maximum permissible discount offered pursuant to such plan.

## Exhibit 5.1

**Exhibit 5.1**

February 23, 2023

Shattuck Labs, Inc.

500 W. 5th Street, Suite 1200

Austin, TX 78701

Re:&nbsp;&nbsp;&nbsp;&nbsp;*Form S-8 Registration Statement for 2020 Equity Incentive Plan and 2020 Employee Stock Purchase Plan*

Ladies and Gentlemen:

We have examined the Registration Statement on Form S-8, (the "Registration Statement") of Shattuck Labs, Inc., a Delaware corporation (the "Company"), to be filed with the Securities and Exchange Commission (the "Commission") pursuant to the Securities Act of 1933, as amended (the "Securities Act"), in connection with the offering by the Company of (i) up to 1,695,623 shares of its common stock, par value $0.0001 per share (the "Common Stock"), available for issuance under the Shattuck Labs, Inc. 2020 Equity Incentive Plan (the "2020 Plan") and (ii) up to 423,905 shares of Common Stock available for issuance under the Shattuck Labs, Inc. 2020 Employee Stock Purchase Plan (the "ESPP" and, together with the 2020 Plan, the "Plans," and such shares of Common Stock, collectively, the "Shares").

We have examined the originals, or photostatic or certified copies, of such records of the Company and certificates of officers of the Company and of public officials and such other documents as we have deemed relevant and necessary as the basis for the opinions set forth below. In our examination, we have assumed the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals and the conformity to original documents of all documents submitted to us as copies. We have also assumed that there are no agreements or understandings between or among the Company and any participants in one or more of the Plans that would expand, modify or otherwise affect the terms of the applicable Plan or the respective rights or obligations of the participants thereunder. Finally, we have assumed the accuracy of all other information provided to us by the Company during the course of our investigations, on which we have relied in issuing the opinion expressed below.

Based upon the foregoing examination and in reliance thereon, and subject to the qualifications, assumptions and limitations stated herein and in reliance on the statements of fact contained in the documents that we have examined, we are of the opinion that the Shares, when issued and sold in accordance with the terms set forth in the applicable Plan and against payment therefor, and when the Registration Statement has become effective under the Securities Act, will be validly issued, fully paid and non-assessable.

We render no opinion herein as to matters involving the laws of any jurisdiction other than the Delaware General Corporation Law (the "DGCL"). We are not admitted to practice in the State of Delaware; however, we are generally familiar with the DGCL as currently in effect and have made such inquiries as we consider necessary to render the opinions above. This opinion is limited to the effect of the current state of the DGCL and the facts as they currently exist. We assume no obligation to revise or supplement this opinion in the event of future changes in such law or the interpretations thereof or such facts.

------

&nbsp;&nbsp;&nbsp;&nbsp;

We consent to the filing of this opinion as an exhibit to the Registration Statement, and we further consent to the use of our name under the caption "Legal Matters" in the Registration Statement and the prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission.

Very truly yours,

/s/ Gibson, Dunn & Crutcher LLP

## Exhibit 23.1

**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

We consent to the use of our report dated February 23, 2023, with respect to the financial statements of Shattuck Labs, Inc., incorporated herein by reference.

/s/ KPMG LLP

Austin, Texas

February 23, 2023

<br>